NO970412L - Indol-, indazol-, pyridopyrrol- og pyridopyrazolderivater med antiastmatisk, antiallergisk, anti-inflammatorisk og immunomodulerende virkning - Google Patents

Indol-, indazol-, pyridopyrrol- og pyridopyrazolderivater med antiastmatisk, antiallergisk, anti-inflammatorisk og immunomodulerende virkning

Info

Publication number
NO970412L
NO970412L NO970412A NO970412A NO970412L NO 970412 L NO970412 L NO 970412L NO 970412 A NO970412 A NO 970412A NO 970412 A NO970412 A NO 970412A NO 970412 L NO970412 L NO 970412L
Authority
NO
Norway
Prior art keywords
pyridin
indol
alkyl
compounds
fluorobenzyl
Prior art date
Application number
NO970412A
Other languages
English (en)
Norwegian (no)
Other versions
NO970412D0 (no
Inventor
Guillaume Lebaut
Fabienne Fouchard
Bernhard Kutscher
Peter Emig
Ilona Fleischhauer
Juergen Schmidt
Stefan Szelenyi
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19511916A external-priority patent/DE19511916A1/de
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of NO970412D0 publication Critical patent/NO970412D0/no
Publication of NO970412L publication Critical patent/NO970412L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
NO970412A 1994-08-03 1997-01-30 Indol-, indazol-, pyridopyrrol- og pyridopyrazolderivater med antiastmatisk, antiallergisk, anti-inflammatorisk og immunomodulerende virkning NO970412L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4427393 1994-08-03
DE19511916A DE19511916A1 (de) 1994-08-03 1995-03-31 Neue N-Benzylindol- und Benzopyrazol-Derivate mit antiasthmatischer, antiallergischer, entzündungshemmender und immunmodulierender Wirkung
PCT/EP1995/002867 WO1996004266A2 (de) 1994-08-03 1995-07-20 Indol-, indazol-, pyridopyrrol- und pyridopyrazol-derivate mit antiasthmatischer, antiallergischer, entzündungshemmender und immunmodulierender wirkung

Publications (2)

Publication Number Publication Date
NO970412D0 NO970412D0 (no) 1997-01-30
NO970412L true NO970412L (no) 1997-02-27

Family

ID=25938901

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970412A NO970412L (no) 1994-08-03 1997-01-30 Indol-, indazol-, pyridopyrrol- og pyridopyrazolderivater med antiastmatisk, antiallergisk, anti-inflammatorisk og immunomodulerende virkning

Country Status (13)

Country Link
US (1) US5965582A (tr)
EP (1) EP0775131A2 (tr)
JP (1) JPH10503501A (tr)
AU (1) AU3162695A (tr)
CA (1) CA2195850A1 (tr)
EG (1) EG21559A (tr)
FI (1) FI971334A7 (tr)
HR (1) HRP950435A2 (tr)
IL (1) IL114795A (tr)
NO (1) NO970412L (tr)
TR (1) TR199500952A2 (tr)
TW (1) TW434227B (tr)
WO (1) WO1996004266A2 (tr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI971334A7 (fi) * 1994-08-03 1997-04-01 Asta Medica Ag Indoli-, indatsoli-, pyridopyrroli- ja pyridopyratsolijohdannaiset, jo illa on antiastmaattinen, antiallerginen, anti-inflammatorinen ja immu nomoduloiva vaikutus
FR2732969B1 (fr) * 1995-04-14 1997-05-16 Adir Nouveaux composes pyridiniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ATE247104T1 (de) * 1997-11-05 2003-08-15 Neurosearch As Azaring-ether-derivate und ihre verwendung als nicotinic-ach-rezeptormodulatoren
US6673827B1 (en) 1999-06-29 2004-01-06 The Uab Research Foundation Methods of treating fungal infections with inhibitors of NAD synthetase enzyme
US6861448B2 (en) * 1998-01-14 2005-03-01 Virtual Drug Development, Inc. NAD synthetase inhibitors and uses thereof
WO1999036422A1 (en) 1998-01-14 1999-07-22 The Uab Research Foundation Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections with inhibitors of bacterial nad synthetase enzyme
TR200003130T2 (tr) 1998-04-28 2001-01-22 Arzneimittelwerk Dresden Gmbh Yeni hidroksiindoller, bunların fosfodiesteraz 4 inhibitörleri olarak kullanımları ve hazırlanmaları için işlemler
DE19821002A1 (de) * 1998-05-11 1999-11-18 Dresden Arzneimittel Neue 1,5- und 3-O-substituierte 1H-Indazole mit antiasthmatischer, antiallergischer, entzündungshemmender, immunmodulierender und neuroprotektiver Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US6362213B1 (en) 1999-12-23 2002-03-26 Icos Corporation Cyclic AMP-specific phosphodiesterase inhibitors
US7217722B2 (en) 2000-02-01 2007-05-15 Kirin Beer Kabushiki Kaisha Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
DE10037310A1 (de) * 2000-07-28 2002-02-07 Asta Medica Ag Neue Indolderivate und deren Verwendung als Arzneimittel
AU2002323474B2 (en) * 2001-09-13 2006-10-05 Synta Pharmaceuticals Corp 3-glyoxlylamideindoles for treating cancer
SE0200411D0 (sv) * 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
SE0200356D0 (sv) * 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
US20040048866A1 (en) * 2002-03-08 2004-03-11 Teodozyj Kolasa Indazole derivatives that are activators of soluble guanylate cyclase
US20050089559A1 (en) * 2003-10-23 2005-04-28 Istvan Szelenyi Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
ATE460415T1 (de) * 2004-11-29 2010-03-15 Warner Lambert Co Therapeutische pyrazoloä3,4-büpyridine und - indazole
US7825154B2 (en) * 2005-08-12 2010-11-02 The United States Of America As Represented By The Secretary Of The Army Small molecule inhibitors of botulinum neurotoxins
US8884020B2 (en) * 2006-08-07 2014-11-11 Ironwood Pharmaceuticals, Inc. Indole compounds
US8722929B2 (en) * 2006-10-10 2014-05-13 Valeant Pharmaceuticals International N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
US8367684B2 (en) * 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
US8563566B2 (en) * 2007-08-01 2013-10-22 Valeant Pharmaceuticals International Naphthyridine derivatives as potassium channel modulators
US7786146B2 (en) * 2007-08-13 2010-08-31 Valeant Pharmaceuticals International Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
TW200924781A (en) 2007-09-14 2009-06-16 Janssen Pharmaceutica Nv Thieno- and furo-pyrimidine modulators of the histamine H4 receptor
AR084433A1 (es) 2010-12-22 2013-05-15 Ironwood Pharmaceuticals Inc Inhibidores de la faah y composiciones farmaceuticas que los contienen
US20140315956A1 (en) * 2011-07-29 2014-10-23 Nationwide Children's Hospital Small molecule inhibitors of il-6 and uses thereof
US9862698B2 (en) 2014-12-16 2018-01-09 Adt Pharmaceuticals, Inc. Indenyl compounds, pharmaceutical compositions, and medical uses thereof
US20160168108A1 (en) 2014-12-16 2016-06-16 Adt Pharmaceuticals, Inc. Method of treating or preventing ras-mediated diseases
JP7169008B2 (ja) 2018-04-26 2022-11-10 エーディーティー ファーマシューティカルズ，エルエルシー 抗がんインデン、インダン、アザインデン、アザインダン、医薬組成物および使用
WO2022211518A1 (ko) * 2021-04-02 2022-10-06 파렌키마바이오텍 주식회사 신규 화합물 및 이의 건선, 천식 또는 전신홍반루푸스의 치료 용도

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US33833A (en) * 1861-12-03 Improved baby jumper and supporter
GB944443A (tr) * 1959-09-25 1900-01-01
NL127797C (tr) * 1961-02-08
US3182071A (en) * 1961-06-27 1965-05-04 Warner Lambert Pharmaceutical Acylated indole derivatives
US3238215A (en) * 1963-10-17 1966-03-01 Sterling Drug Inc 1-[(3-, 2-, and 1-indolyl)-lower-alkyl-, lower-alkenyl-, and lower-alkynyl]piperidines
US3445472A (en) * 1965-12-03 1969-05-20 American Home Prod Mono- and di-aroyl pyridylethyl and piperidylethyl indoles
MC614A1 (fr) * 1966-04-21 1967-05-31 Cerm Cent Europ Rech Mauvernay Nouveau composé analgésique et anti-inflammatoire.
IL28032A (en) * 1966-08-29 1971-08-25 Acraf Indazol-3-yl-oxyalkanoic acids and process for the preparation thereof
BE795457A (fr) * 1972-02-16 1973-08-16 Clin Midy Amines indoliques, leur preparation et leur application en therapeutiques
US4350634A (en) * 1977-07-12 1982-09-21 Sandoz Ltd. N-Benzoyl-N'-3-indolyl-N'alkyl-1,3-diaminopropanes
JPS55105664A (en) * 1979-02-08 1980-08-13 Kawaken Fine Chem Co Ltd Preparation of tryptamine
US4359468A (en) * 1981-02-25 1982-11-16 Boehringer Ingelheim Ltd. Antiallergic N-[4-(indolyl)-piperidino-alkyl]-benzimidazolones
US4760074A (en) * 1983-04-22 1988-07-26 Janssen Pharmaceutica N.V. Novel-N-(bicyclic heterocyclyl)-4-piperidinamines
USRE33833E (en) 1982-07-12 1992-02-25 Janssen Pharmaceutica N.V. Novel N-(bicyclic heterocyclyl)-4-piperidinamines
US4820822A (en) * 1982-07-12 1989-04-11 Janssen Pharmaceutica Novel N-(bicyclic heterocyclyl)-4-piperidinamines
US4556660A (en) * 1982-07-12 1985-12-03 Janssen Pharmaceutica N.V. N-(Bicyclic heterocyclyl)-4-piperidinamines
JPS5935299A (ja) * 1982-08-20 1984-02-25 三菱電機株式会社 速度違反取締システム
US4743609A (en) * 1985-02-12 1988-05-10 Banyu Pharmaceutical Co., Ltd. Indole derivatives having gastric and antisecretory and cytoprotective properties, and pharmaceutical preparations containing same
GT198900005A (es) * 1988-01-29 1990-07-17 Quinolinas y cinolinas substituidas.
GB8810203D0 (en) * 1988-04-29 1988-06-02 Ici Plc Heterocyclic compounds
JPH0237496A (ja) * 1988-07-28 1990-02-07 Canon Inc 交通監視システム
IL99320A (en) * 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical compositions containing them
PL170330B1 (pl) * 1990-10-15 1996-11-29 Pfizer Sposób wytwarzania nowych pochodnych indolu PL PL PL PL PL PL
BR9206810A (pt) * 1991-11-25 1995-10-31 Pfizer Derivados de indol
US5498626A (en) * 1992-04-10 1996-03-12 Pfizer Inc. Acylaminoindole derivatives as 5-ht1 agonists
FR2705346B1 (fr) * 1993-05-18 1995-08-11 Union Pharma Scient Appl Nouveaux dérivés de pipéridinyl thio indole, leurs procédés de préparation, compositions pharmaceutiques les contenant, utiles notamment comme antalgiques .
DK139593D0 (da) * 1993-12-16 1993-12-16 Lundbeck & Co As H Compounds
FI971334A7 (fi) * 1994-08-03 1997-04-01 Asta Medica Ag Indoli-, indatsoli-, pyridopyrroli- ja pyridopyratsolijohdannaiset, jo illa on antiastmaattinen, antiallerginen, anti-inflammatorinen ja immu nomoduloiva vaikutus

Also Published As

Publication number Publication date
JPH10503501A (ja) 1998-03-31
IL114795A0 (en) 1995-12-08
IL114795A (en) 1999-11-30
WO1996004266A3 (de) 1996-05-17
TW434227B (en) 2001-05-16
HRP950435A2 (en) 1997-12-31
FI971334L (fi) 1997-04-01
US5965582A (en) 1999-10-12
EP0775131A2 (de) 1997-05-28
TR199500952A2 (tr) 1996-07-21
WO1996004266A2 (de) 1996-02-15
EG21559A (en) 2001-12-31
FI971334A0 (fi) 1997-04-01
NO970412D0 (no) 1997-01-30
FI971334A7 (fi) 1997-04-01
AU3162695A (en) 1996-03-04
CA2195850A1 (en) 1996-02-15

Similar Documents

Publication Publication Date Title
NO970412L (no) Indol-, indazol-, pyridopyrrol- og pyridopyrazolderivater med antiastmatisk, antiallergisk, anti-inflammatorisk og immunomodulerende virkning
US6008231A (en) N-substituted indole-3 glyoxylamides having anti-asthmatic antiallergic and immunosuppressant/immuno-modulating action
JP2786480B2 (ja) １―インドリルアルキル―４―（置換ピリジニル）ピペラジン
JP5253696B2 (ja) 抗腫瘍作用を有するインドリル−３−グリオキシル酸誘導体
US5834493A (en) Indole derivatives as 5-HT1A and/or 5-HT2 ligands
KR930001411B1 (ko) 벤즈이미다졸 유도체의 제조방법
US5981525A (en) Indole derivatives useful in the treatment of osteoporosis
IE904146A1 (en) Indole Derivatives
NO309652B1 (no) 5-arylindol-derivater og deres anvendelse, samt farmasöytisk blanding
SK5462003A3 (en) Indolylmaleimide derivatives, method for the preparation thereof and pharmaceutical composition comprising same
US5919811A (en) 3-Substituted-indole-2-carboxylic acid derivatives as excitatory amino acid antagonists
NO166862B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,8-nafthyridinderivater og deres salter, solvater, hydrater og estere.
NZ230068A (en) Indazole-3-carboxylic acid esters and amides of diaza compounds having 6,7, or 8 ring members: preparatory processes and pharmaceutical compositions
PT93977A (pt) Processo para a preparacao de n-hetero-aril-4-quinolinaminas e composicoes farmaceuticas que as contem
SK50895A3 (en) 3-indolylpiperidine derivative, method of its preparation, its use for preparation of pharmaceutical composition and pharmaceutical composition containing them
TW314518B (tr)
MXPA97006605A (en) Indol derivatives as antagonists of amino acids exited
JPS6296465A (ja) 新規ヘテロ環式化合物及びその製法
JP5031171B2 (ja) 新規β−アミロイド阻害剤、その製造方法及び医薬組成物としての使用
JP2006506346A (ja) ｐ３８キナーゼ阻害剤としてのインドール系誘導体
US5380723A (en) Indole derivatives
JPH0826028B2 (ja) ピロロ〔１，２−ａ〕〔４，１〕ベンゾオキサゼピン誘導体
CA1285945C (en) N-¬¬¬1-(2)naphthylenemethyl or quinol-6-ylmethyl)-4- piperidinyl|amino|-carbonyl|-6-quinolinecarboxamide compounds
CA1246573A (en) .alpha.-ARYL-.alpha.-PYRIDYLALKANOIC ACID DERIVATIVES, PROCESS FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
NO166186B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indol-pyrazin-benzodiazepinderivater.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application